Why it was recalled
Lack Of Processing Controls
Product description
Morphine Sulfate (MITIGO), 5 mg/mL intrathecal, 40 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901
Lot numbers, UPCs & expiration codes
Lot 02242020@14
Where it was sold
Sold to patients in Nebraska
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1011-2020
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Feb 24, 2020
- FDA report date
- Mar 18, 2020
- Quantity
- 1 40 ml syringe
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Redline Pharmacy Solutions
Original FDA data
Every field from FDA enforcement report D-1011-2020, exactly as published.
Show all FDA fields
- City
- Hastings
- State
- NE
- Status
- Terminated
- Country
- United States
- Event ID
- 85081
- Address
- 2415 Osborne Dr E Ste 100
- Code information
- Lot 02242020@14
- Postal code
- 68901-1999
- Report date
- Mar 18, 2020
- Product type
- Drugs
- Recall number
- D-1011-2020
- Classification
- Class II
- Recalling firm
- Redline Pharmacy Solutions
- Product quantity
- 1 40 ml syringe
- Termination date
- Mar 31, 2022
- Reason for recall
- Lack Of Processing Controls
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Morphine Sulfate (MITIGO), 5 mg/mL intrathecal, 40 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901
- Distribution pattern
- Sold to patients in Nebraska
- Recall initiation date
- Feb 24, 2020
- Initial firm notification
- Telephone
- Center classification date
- Mar 12, 2020